+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 0 - 15Minutes
All Genders
Healthy Volunteers
ID06007547

Study of Early Surfactant Treatment Using a Minimally Invasive Method in Preterm Infants Under 30 Weeks Gestation to Improve Respiratory Outcomes

Led by Endeavor Health · Updated on 2025-08-07

200

Participants Needed

1

Research Sites

82 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether giving surfactant early in the delivery room using a minimally invasive technique helps improve outcomes for preterm infants born between 22 and 29 weeks of gestation compared to waiting to treat only if needed. This randomized, controlled trial involves multiple hospitals and aims to determine if early surfactant reduces the need for intubation in these very premature babies. In this study, babies are randomly assigned to receive poractant alfa Curosurf surfactant within 15 minutes after birth using a special catheter for minimally invasive surfactant therapy MIST, or to receive the same treatment only if their oxygen needs rise above a certain level within the first 48 hours. Both groups will be supported with nasal continuous positive airway pressure NCPAP or high flow nasal cannula HFNC. A second surfactant dose may be given if oxygen requirements increase again between 6 and 48 hours after the first dose. Babies needing emergency intubation at birth are not included in the treatment part of the trial. Participants will be monitored closely in the neonatal intensive care unit with ongoing respiratory support as needed. Researchers will track whether infants need intubation within the first week, along with other respiratory and non-respiratory health outcomes until hospital discharge. Developmental follow-up assessments at two years corrected age will also be collected. The study plans to enroll about 200 infants over two years to evaluate the impact of early versus rescue surfactant treatment.

CONDITIONS

Brief Title

Prophylactic Minimally Invasive Surfactant Evaluation

Research Team

M

Matthew Derrick, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here